China Health Group Inc. (HKG:8225)

China Health Group Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-14.52	-58.01	-15.83	36.33
Depreciation & Amortization	0.61	0.23	0.15	0.2
Loss (Gain) From Sale of Assets	-	-	-	-0.02
Stock-Based Compensation	0.05	0.51	2.14	0.57
Provision & Write-off of Bad Debts	-	1.2	-	0.38
Other Operating Activities	1.46	0.69	-0.19	2.12
Change in Accounts Receivable	7.82	43.43	19.69	-42.84
Change in Accounts Payable	-3.78	-1.58	-2.03	-3.37
Change in Unearned Revenue	-	-	-	-0.15
Change in Other Net Operating Assets	18.64	14.65	-9.09	-3.5
Operating Cash Flow	10.28	1.12	-5.16	-10.28
Operating Cash Flow Growth	817.39%	-	-	-
Capital Expenditures	-1.76	-6	-	-
Divestitures	-	-	-	0.03
Investment in Securities	1.47	4.85	-2.35	6.5
Other Investing Activities	0.06	0.12	0.2	0.43
Investing Cash Flow	-0.23	-1.04	-2.15	6.96
Short-Term Debt Repaid	-	-	-	-1.5
Total Debt Repaid	-	-	-	-1.5
Net Debt Issued (Repaid)	-	-	-	-1.5
Other Financing Activities	-	-	-	-0.02
Financing Cash Flow	-	-	-	-1.52
Net Cash Flow	10.05	0.08	-7.3	-4.83
Free Cash Flow	8.52	-4.88	-5.16	-10.28
Free Cash Flow Margin	32.22%	-22.79%	-39.39%	-12.29%
Free Cash Flow Per Share	0.01	-0.01	-0.01	-0.01
Cash Interest Paid	-	-	-	0.02
Cash Income Tax Paid	0.19	-	-	3.66
Levered Free Cash Flow	14.04	17.61	0.85	-19.86
Unlevered Free Cash Flow	14.04	17.61	0.87	-19.85
Change in Working Capital	22.68	56.5	8.57	-49.86

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.